Search Results for: wealth

By Kuldip K. Ambastha On the trading day of February 9, 2023, the stock price of Credit Suisse Group AG (CS), a Swiss financial institution, fell by -15.6% per share. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of October 24-28, 2022; By Kuldip K. Ambastha.”) Credit Suisse’s …

Continue reading “What Caught Our Attention in the Investment World? – Week of February 6-10, 2023”

By Kuldip K. Ambastha On Thursday, October 27, 2022, the stock of Credit Suisse Group AG (CS), a prominent Swiss financial institution with operations around the world, had a steep price drop of -20.0% per share for the trading day. Credit Suisse Group in the recent past has had troubles linked to the scandals around …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 24-28, 2022”

By Kuldip K. Ambastha During this week, both J.Crew and Neiman Marcus announced their respective bankruptcy filings. The retail industry has been on fragile ground for many years now, and the coronavirus pandemic has pushed both of these companies into bankruptcy. Due to the public health issues around the coronavirus, brick-and-mortar retailers have had to …

Continue reading “What Caught Our Attention in the Investment World? – Week of May 4-8, 2020”

By Kuldip K. Ambastha Carnival Corporation (CCL) is well-known as a cruise operator and as a prominent travel / leisure company. This British-American company has struggled recently due to the coronavirus pandemic seen worldwide. However, during this week, the company had strong days on Monday, April 6, 2020 and Tuesday, April 7, 2020, returning 20.3% …

Continue reading “What Caught Our Attention in the Investment World? – Week of April 6-10, 2020”

By Kuldip K. Ambastha and Anil K. Ambastha Karuna Therapeutics Inc. (KRTX), a clinical-stage biopharmaceutical company, was founded in 2009 and is headquartered in Boston, MA. The company is focused on developing innovative therapies for individuals suffering from disabilities, disorders, and pain. Karuna Therapeutics Inc. has announced that its schizophrenia treatment’s Phase 2 clinical trial …

Continue reading “What Caught Our Attention in the Investment World? – Week of November 18-22, 2019”